Intravenously Administered Tissue Plasminogen Activator Useful in Milder Strokes? A Meta-analysis

Conclusions: Patients with mild stroke may derive benefit from intravenous thrombolysis without a significant increase in mortality.

Source: Journal of Stroke and Cerebrovascular Diseases - August 11, 2014 Category: Neurology Authors: Leonard L.L. Yeo, Roger Ho, Prakash Paliwal, Rahul Rathakrishnan, Vijay K. Sharma Tags: Original Articles Source Type: research